UBS maintains Viavi Solutions at Neutral, lowers price target to $33 from $44

UBS kept its Neutral rating on Viavi Solutions but cut its price target to $33 from $44, a 25% reduction. This suggests a 25.5% upside from the Nov 5 closing price of $26.30, according to UBS.

Original reporting
Published Nov 6, 2026, 1:20 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 1:28 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
UBS maintains Viavi Solutions at Neutral, lowers price target to $33 from $44 — source image
Decision brief

The 30-second read

$VIAVBearishLow
01

Why it matters

The downgrade could trigger short‑term selling pressure, especially among momentum traders.

02

Market read

A modest analyst target cut for a small‑cap stock; limited broader market impact.

03

What to watch

Potential upside from upcoming product launches or new service contracts not captured in the analyst note.

Relevance 5/10Novelty 5/10Timing: pre‑market today

Background

UBS analyst maintains a neutral rating but reduces the price target, indicating a less optimistic outlook for Viavi Solutions.

Company-level read

Ticker impact

$VIAVBearishMedium confidence
Context

UBS lowered its price target for Viavi Solutions from $44 to $33, a 25% reduction.

Expected impact

potential downward pressure as the market prices in the lower target

Evidence & confidence

Analyst target reductions often lead to short-term sell pressure, especially for small‑cap stocks.

Market effects

Minimal; the downgrade is specific to Viavi and does not signal broader sector trends.

U.S. market focus; no regional spillover.

Low; limited to investors tracking Viavi Solutions.

Counterpoint

The target cut may be overly pessimistic if recent contract wins are not yet reflected in the price.

Key entities

  • Viavi Solutions

    Provider of network testing, monitoring, and assurance solutions.

  • UBS

    Investment bank issuing the rating and target change.

Related articles

$VIAVMedAI 8/10

Viavi Solutions (VIAV) Q1 2027 Earnings Call Transcript

Viavi Solutions (VIAV) reported Q1 2027 revenue of $469.3M, up 5.9% sequentially and 56.9% year-over-year, exceeding guidance. Operating margin was 29%, with EPS at $0.47. NSC revenue grew 74.1% YoY, driven by data center and aerospace/defense demand. OSP revenue rose 12.2% YoY. The company repurchased $150M in shares and announced a new $500M buyback plan. Q2 guidance projects revenue of $505M-$515M, with EPS between $0.50-$0.52.

$VIAVMed

Viavi Solutions Q1 Earnings Call Highlights

Viavi Solutions (VIAV) reported Q1 earnings, with executives projecting sequential revenue growth driven by data centers, aerospace, and service providers. They forecast a Q2 operating margin of 29.3%. The company sees a multiyear service-provider equipment refresh cycle and a growing semiconductor test market. Operating cash flow rose to $104.7M, and Viavi repurchased 3.95M shares for $150M, with a new $500M buyback plan approved.

$VIAVHighAI 8/10

Viavi Solutions: Fiscal Q1 Earnings Snapshot

Viavi Solutions Inc. (VIAV) reported fiscal Q1 net income of $76M, or 29 cents per share, with adjusted EPS of 47 cents, beating analyst estimates. Revenue was $469.3M, also exceeding forecasts. The company expects Q2 EPS of 50-52 cents and revenue of $505M-$515M.